Michael Caplan

Michael Caplan serves as the Director of Quality Assurance at GSK since August 2022, following a similar role at Aclaris Therapeutics, Inc. from July 2021 to August 2022. Prior experience includes serving as Associate Director of External Quality at Merck from June 2020 to July 2021, focusing on third-party quality management for clinical supplies. At AstraZeneca, between January 2011 and June 2020, Michael held multiple positions, including Lead Quality Assurance Advisor and Quality Director for Standards and Systems, providing strategic quality advice and overseeing compliance in various capacities. Michael's early career includes chairing the GMP Clinical Supplies Roundtable Conference in 2005 and being a steering committee member from 2003 to 2005 and from 2010 to the present. Academic credentials include an MBA in Operations Management and Supervision from Drexel University and an MS in Quality Assurance and Regulatory Affairs from Temple University.